Autoimmunovascular regulation: Morphine and ancondamide and ancondamide stimulated nitric oxide release

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 70-76

  Stefano, George B ^a  

^a Old Westbury Neurosci Res I   (United States)

Author keywords

Autoimmunovascular regulation; Morphine; Nitric oxide; Opiate receptor

Indexed keywords

ANANDAMIDE; ANCONDAMIDE; CANNABINOID; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MORPHINE; MU OPIATE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKOCYTE ADHERENCE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ARACHIDONIC ACIDS; CANNABINOIDS; ENDOTHELIUM, VASCULAR; HUMANS; MORPHINE; NARCOTICS; NEUROGLIA; NEUROIMMUNOMODULATION; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES; RECEPTORS, OPIOID, MU;

EID: 0032520652     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00223-3     Document Type: Article

References (60)

1. Bath P.M.W., Hasall D.G., Gladwin A.M., Palmer R.M., Martin J.F. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. 11:1991;254-260.
2. Bhargava H.N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26(5):1995;1049-1053.
3. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11:1993;767-804.
4. Bilfinger T.V., Hartman A., Liu Y., Magazine H.I., Stefano G.B. Cryopreserved veins used for myocardial revascularization: a 5-year experience and a possible mechanism for their increased failure. Ann. Thorac. Surg. 63:1997;1063-1069.
5. Burnette-Curley D., Cabral G.A. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proc. Soc. Exp. Biol. Med. 210:1995;64-76.
6. Cabral, G.A., Fischer-Stenger, K., 1994. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. 54, 1831-1844.
7. Calignano A., Persico P., Mancuso F., Sorrentino L. Endogenous nitric oxide modulates morphine-induced-changes in locomotion and food intake in mice. Eur. J. Pharmacol. 321:1993;415.
8. Curnow K.M., Pascoe L., Davies E., White P.C., Corvol P., Clauser E. Alternatively spliced human type I angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol. Endocrinol. 9:1995;1250-1262.
9. Dambisya Y.M., Lee T.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br. J. Pharmacol. 117(5):1996;914-918.
10. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96(1):1995;60-81.
11. Dembinska-Kiec A., Zmuda A., Wenhrynowicz O., Stachura J., Peskar B.A., Gryglewski R.J. Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int. J. Tissue React. 15(2):1993;55-64.
12. Duarte I.D., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 221:1992;171.
13. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152:1994;5845.
14. Ferreira S.H., Duarte I.D., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201:1991;121.
15. Fricchione G.L., Stefano G.B. The stress response and autoimmunoregulation. Adv. Neuroimmunol. 4:1994;13-28.
16. Friedman M., Cepero M.L., Klein T., Friedman H. Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc. Soc. Exp. Biol. Med. 182:1986;225-228.
17. Gyires K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol. 255:1994;33.
18. Hollister L.E. Marijuana and immunity. J. Psychoactive Drugs. 24:1992;159-164.
19. Kaufman D.L., Keith D.E. Jr., Anton B., Tian J., Magendzo K., Newman D., Tran T.H., Lee D.S., Wen C., Xia Y.R. Characterization of the murine mu opioid receptor gene. J. Biol. Chem. 270:1995;15877-15883.
20. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.A. Blockade of tolerance to morphine but not to k opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5162-5166.
21. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262:1992;H611-H615.
22. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4651-4655.
23. Kubes P., Kanwar S., Niu X.F., Gabourg J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
24. Kubes P., Kurose I., Granger D.N. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267(3 Pt 2):1994;H931-H937.
25. Kurose I., Kubes P., Wolf R. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ. Res. 73:1993;164-171.
26. Kurose I., Wolf R., Granger D.N. Dimethyl-L-arginine, an endogenous inhibitor of nitric oxide (NO) synthesis, elicits an inflammatory response in the rat mesenteric microcirculation. Abstr. Gastroenterol. 106:1994;A245.
27. Liu, Y., Shenouda, D., Bilfinger, T.V., Stefano, M.L., Magazine, H.I., Stefano, G.B., 1997. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res., in press.
28. Lopez-Cepero M., Friedman M., Klein T., Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukocyte Biol. 39:1986;679-686.
29. Luscinskas F.W., Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8:1994;929-939.
30. Ma X.L., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72:1993;403-412.
31. Magazine, H.I., Liu, Y., Bilfinger, T.V., Fricchione, G.L., Stefano, G.B., 1996. Morphine-induced conformational changes in immunocytes, endothelial cells and microglia are mediated by nitric oxide. J. Immunol., in press.
32. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189.
33. McCoy K.L., Gainey D., Cabral G.A. delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273:1995;1216-1223.
34. McEver R.P. Selectins. Curr. Opin. Immunol. 6:1994;75-84.
35. Munro, S., Thomas, K.L., Abu-Shaar, M., 1993. Molecular characterization of a peripheral receptor for cannabinoids. 365, 61-65.
36. Niu X.F., Smith C.W., Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74(6):1995;1133-1140.
37. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 70:1990;427-451.
38. Prezewlocki R., Machelska H., Prezwlocka B. Inhibition of nitric oxide synthetase enhances morphine antinociception in the rat spinal cord. Life Sci. 53:1993;PL1.
39. Radomski M.W., Palmer R.M.J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. ii:1987;1057-1058.
40. Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. Antisense mapping of the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett. 369:1995;192-196.
41. Scabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 3:1995;2-32.
42. Shivers, S.C., Newton, C., Friedman, H., Klein, T., 1994. delta-9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. 54, 1281-1289.
43. Simon D.I., Stamler J.S., Jaraki O., Keany J.F., Osborne J.A., Francis S.A., Singel D.J., Loscalzo J. Anti-platelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 13:1993;791-799.
44. 9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. 13:1991;411-417.
45. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell. 67:1994;301-314.
46. Stefano G.B. Role of opioid neuropeptides in immunoregulation. Prog. Neurobiol. 33:1989;149-159.
47. Stefano G.B., Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv. Neuroimmunol. 4:1994;57-68.
48. Stefano G.B., Paemen L.R., Hughes T.K. Autoimmunoregulation: differential modulation of CD10/neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides. J. Neuroimmunol. 41:1992;9-14.
49. 3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270:1995;30290-30293.
50. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
51. Stefano G.B., Liu Y., Goligorsky M.S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia and human monocytes. J. Biol. Chem. 271:1996;19238-19242.
52. Stefano, G.B., Salzet, M., Magazine, H.I., Bilfinger, T.V., 1998. Antagonism of LPS and IFN-(induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J. Cardiovasc. Pharm., (in press).
53. Suematsu M., Tamatani T., Delano F.A., Miyasaka M., Forrest M., Suzuki H., Schmid-Schonbein G.W. Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. Am. J. Physiol. 266:1994;H2410-H2415.
54. Tang J.-L., Lancz G., Spector S., Bullock H. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic acitivity of the murine macrophage cell line, P388D1. Int. J. Immunopharmacol. 14:1992;253-262.
55. Vaupel D.B., Kimes A.S., London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opiopid withdrawal. Psychopharmacology. 118(4):1995;361-368.
56. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors-preclinical studies of potential use for the treatment of opioid withdrawal. Neuropsychopharmacology. 13(4):1995;315-322.
57. Vidal M.J., Zocchi M.R., Poggi A., Pellegatta F., Chierchia S.L. Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells. J. Cardiovasc. Pharmacol. 20(12):1992;S155-S159.
58. Xu J.Y., Tseng L.F. Nitric oxide cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 274(1):1995;8-16.
59. Zheng Z.M., Spector S., Friedman H. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol. 14:1992;1445-1452.
60. Zimprich A., Simon T., Hollt V. Cloning and expression of anisoform of the rat mu opioid receptor (rMORiB) which differs in agonist induced desensitization from rMOR1. FEBS Letts. 359:1995;142-146.